Cargando…
Synergistic Apoptosis Induction in Leukemic Cells by the Phosphatase Inhibitor Salubrinal and Proteasome Inhibitors
BACKGROUND: Cells adapt to endoplasmic reticulum (ER)-stress by arresting global protein synthesis while simultaneously activating specific transcription factors and their downstream targets. These processes are mediated in part by the phosphorylation-dependent inactivation of the translation initia...
Autor principal: | Drexler, Hannes C. A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2613525/ https://www.ncbi.nlm.nih.gov/pubmed/19129918 http://dx.doi.org/10.1371/journal.pone.0004161 |
Ejemplares similares
-
Synergistic antitumor activity of the combination of salubrinal and rapamycin against human cholangiocarcinoma cells
por: Zhao, Xiaofang, et al.
Publicado: (2016) -
Neuroprotective Effect of the Inhibitor Salubrinal after Cardiac Arrest in a Rodent Model
por: Zhang, Jincheng, et al.
Publicado: (2020) -
Resveratrol protects leukemic cells against cytotoxicity induced by proteasome inhibitors via induction of FOXO1 and p27(Kip1)
por: Niu, Xiao-Fang, et al.
Publicado: (2011) -
Protein Kinase Cδ Stimulates Proteasome-Dependent Degradation of C/EBPα during Apoptosis Induction of Leukemic Cells
por: Zhao, Meng, et al.
Publicado: (2009) -
Molecular docking studies of salubrinal and its analogs as inhibitors of the GADD34:PP1 enzyme
por: Zadorozhnii, Pavlo V., et al.
Publicado: (2019)